VKTX ▲ +0.5% - Viking Therapeutics, Inc.
$VKTX VKTX VKTK - Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity
14-OCT-2026 07:05 AM ET
Share this post
More filings for $VKTX
VKTX ▼ -1.7% - Viking Therapeutics, Inc.Oct 12, 2026VKTX ▲ +1.3% - Viking Therapeutics, Inc.Oct 7, 2026VKTX ▲ +1.0% - Viking Therapeutics, Inc.Oct 6, 2026VKTX ▼ -6.6% - Viking Therapeutics, Inc.Sep 28, 2026VKTX ▼ -10.6% - Viking Therapeutics, Inc.Sep 24, 2026VKTX ▼ -5.8% - Viking Therapeutics, Inc.Sep 23, 2026
View full $VKTX filing history →💬 Comments
Loading comments…
Leave a comment